NEU neuren pharmaceuticals limited

Ann: Neuren and Acadia expand global partnership for trofinetide, page-108

  1. 150 Posts.
    lightbulb Created with Sketch. 107
    Goldenchook: "I kid you not. Please show me figures that refute those".

    1) Nearly 20% of patients went off the medication after only 12 weeks. There is no evidence yet to suppose that number will significantly decrease.

    2) Potential patient estimates derived by applying the mid-point of the published prevalence estimate range to the populations under 60 years. In other words, it's simply a prevalence estimate. There is no hard data to suggest it's accurate. Stick to known patient populations.

    FWIW I tend to broadly agree with the Wilsons Equity research -which is based on reasonable assumptions not hocus pocus.

    We've had some very good news the other day, and expect more good news in the near future. Be happy with that.
    Don't let greed carry you away.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.